PD42: Bladder Cancer: Invasive IV

Sunday, May 15, 2022

9:30 AM – 11:30 AM

Location: Room 245

Podium Session Moderator(s)

Khurshid Guru, MD

Director of Robohe Surgery
Roswell Park Comprehensive Cancer Center
DS

D. Robert Siemens, MD,FRCSC (he/him/his)

Queen's University

Presentations:

9:30 AM – 9:40 AM

PD42-01: Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): a multi-institutional study
Podium Presenter: Alexandre R. Zlotta, MD, PHD, FRCSC – Mount Sinai Hospital
9:40 AM – 9:50 AM

PD42-02: Results of the intracorporeal robotic vs open cystectomy (iROC) multi-centre randomised trial.
Podium Presenter: Pramit Khetrapal, MBBS – UCL
9:50 AM – 10:00 AM

PD42-03: Oncologic surveillance intensity for variant histology versus pure urothelial carcinoma of the bladder after radical cystectomy
Podium Presenter: Giuseppe Basile, MD
10:00 AM – 10:10 AM

PD42-04: Predictive value of serum levels of squamous cell carcinoma associated antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 in urothelial cancer of the urinary bladder
Podium Presenter: Yasuyoshi Miyata, MD, PHD – Nagasaki University Hospital
10:10 AM – 10:20 AM

PD42-05: Expanding the use of targeted therapy for urothelial bladder cancer (UBC): Non-FGFR3 receptor tyrosine kinase (RTK) gene rearrangements (ReAr) and fusions (fus)
Podium Presenter: Kyle M. Rose, MD,MS
10:20 AM – 10:30 AM

PD42-06: The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): An Updated Comprehensive Multi-institutional, Multi-readers Systematic Review and Meta-analysis from diagnostic evidence into future clinical recommendations
Podium Presenter: Francesco Del Giudice, MD
10:30 AM – 10:40 AM

PD42-07: Radical vs Partial Cystectomy for Urachal Carcinoma: A Population-Based Analysis
Podium Presenter: Rocco Simone Flammia, MD (he/him/his)
10:40 AM – 10:50 AM

PD42-08: Real-World Performance of MRI After TURBT in Predicting Final Pathologic Outcomes in Bladder Cancer
Podium Presenter: Thomas S. Gerald, MD
10:50 AM – 11:00 AM

PD42-09: Do Prophylactic Antibiotics Reduce Urinary Tract Infections Following Robot-Assisted Radical Cystectomy? A Randomized Control Trial
Podium Presenter: Yousuf Omar Ramahi, BS
11:00 AM – 11:10 AM

PD42-10: Independent Predictors and Patterns of Early and Late Recurrence after Radical Cystectomy for Bladder Cancer: a Multicenter Collaboration
Podium Presenter: Chiara Lonati, MD
11:10 AM – 11:20 AM

PD42-11: Comparison of Comprehensive Complication Index and Clavien-Dindo Classification to Estimate Perioperative Morbidity in Bladder Cancer Patients with Complete Intracorporeal Robot-assisted Radical Cystectomy
Podium Presenter: Sami-Ramzi Leyh-Bannurah, MD – Urology, Pediatric Urology and Urologic Oncology,
11:20 AM – 11:30 AM

PD42-12: Modeling the Contribution of Preoperative VI-RADS Score to Predict Final Pathologic Lymph-Nodes Involvement in Patients with MIBC Undergone Radical Cystectomy
Podium Presenter: Francesco Del Giudice, MD